In vitro insights into the influence of marrow mesodermal/mesenchymal progenitor cells on acute myelogenous leukemia and myelodysplastic syndromes

J Liesveld, J Galipeau - Stem Cells, 2023 - academic.oup.com
The study of marrow-resident mesodermal progenitors can provide important insight into
their role in influencing normal and aberrant hematopoiesis as occurs in acute myelogenous …

Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms

AK Brenner, I Nepstad, Ø Bruserud - Frontiers in immunology, 2017 - frontiersin.org
Acute myeloid leukemia (AML) is a bone marrow malignancy, and various bone marrow
stromal cells seem to support leukemogenesis, including osteoblasts and endothelial cells …

Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors

P Chandran, Y Le, Y Li, M Sabloff, J Mehic… - Leukemia research, 2015 - Elsevier
The bone marrow microenvironment may be permissive to the emergence and progression
of acute myeloid leukemia (AML). Studying interactions between the microenvironment and …

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support …

G Corradi, C Baldazzi, D Očadlíková, G Marconi… - Stem cell research & …, 2018 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) are an essential element of the
bone marrow (BM) microenvironment, playing a crucial function in regulating hematopoietic …

Mesenchymal stem and progenitor cells in normal and dysplastic hematopoiesis—masters of survival and clonality?

L Pleyer, P Valent, R Greil - International journal of molecular sciences, 2016 - mdpi.com
Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders that
have the capacity to progress to acute myeloid leukemia (AML). Accumulating evidence …

Detailed characterization of mesenchymal stem/stromal cells from a large cohort of AML patients demonstrates a definitive link to treatment outcomes

RD de la Guardia, B Lopez-Millan, JR Lavoie, C Bueno… - Stem Cell Reports, 2017 - cell.com
Bone marrow mesenchymal stem/stromal cells (BM-MSCs) are key components of the
hematopoietic niche thought to have a direct role in leukemia pathogenesis. BM-MSCs from …

The Yin and Yang of the bone marrow microenvironment: pros and cons of mesenchymal stromal cells in acute myeloid leukemia

M Ciciarello, G Corradi, F Loscocco, G Visani… - Frontiers in …, 2019 - frontiersin.org
Mesenchymal stromal cells (MSCs) have, for a long time, been recognized as pivotal
contributors in the set up and maintenance of the hematopoietic stem cell (HSC) niche, as …

Mesenchymal stem cells in myeloid malignancies: A focus on immune escaping and therapeutic implications

NS Fracchiolla, B Fattizzo… - Stem cells …, 2017 - Wiley Online Library
The importance of the bone marrow microenvironment forming the so‐called niche in
physiologic hemopoiesis is largely known, and recent evidences support the presence of …

Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia

S Geyh, M Rodriguez-Paredes, P Jäger… - Leukemia, 2016 - nature.com
Hematopoietic insufficiency is the hallmark of acute myeloid leukemia (AML) and
predisposes patients to life-threatening complications such as bleeding and infections …

Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts

E Fathi, Z Sanaat, R Farahzadi - Blood research, 2019 - synapse.koreamed.org
Drug resistance in cancer, especially in leukemia, creates a dilemma in treatment planning.
Consequently, studies related to the mechanisms underlying drug resistance, the molecular …